Senate Democrats plan to use the confirmation battle for Brett Kavanaugh's to the Supreme Court of the United States to mobilize their base around threats to the Affordable Care Act (ACA), the social safety net, and reproductive rights; a Texas courtroom will be the setting for another critical chapter in the fate of the ACA; consumers who buy insurance through ACA markets will find premiums have stabilized in 2019.
Senate Democrats plan to use the confirmation battle for Brett Kavanaugh's nomination to the Supreme Court of the United States to mobilize their base around threats to the Affordable Care Act (ACA), the social safety net, and reproductive rights to build victories for November midterms, Politico reported. Democrats have a very slim chance to stop the nomination of the appellate court justice, and say they are planning to ask hard-hitting questions on a variety of topics. But Senate Republicans have already signaled they’ll rebuff efforts to divine Kavanaugh’s views on active cases.
Against the backdrop of confirmation hearings for Kavanaugh in the nation’s capitol, a Texas courtroom will be the setting Wednesday for another critical chapter in the fate of the ACA. A group of Republican attorneys general will face off against a group of Democratic attorneys general in a lawsuit aimed at striking down the ACA. The Republicans say that when Congress eliminated the individual mandate for not having health insurance as part of last year’s tax bill, lawmakers rendered the entire health law unconstitutional. While the defendant is technically the Trump administration, the administration announced it would not fully defend the law in court, Kaiser Health News reported.
Consumers who buy insurance through ACA markets will find premiums have stabilized in 2019, NPR reported. In addition, insurers are expanding their offerings. The price of a 2019 policy sold on the ACA exchanges will increase less than 4%, according to an analysis of preliminary filings from insurers in all 50 states by ACASignups.net, a website and blog run by analyst Charles Gaba that tracks ACA enrollment and insurer participation.
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Disease-Modifying Antirheumatic Drugs Linked to Decreased Risk for Autoimmune Thyroid Disease
November 28th 2023A nationwide cohort study linked biologic disease-modifying antirheumatic drugs with decreased risks for the onset of autoimmune thyroid disease in patients with rheumatoid arthritis.
Read More
Insufficient Data, Disparities Plague Lung Cancer Risk Factor Documentation
September 24th 2023On this episode of Managed Care Cast, we speak with the senior author of a study published in the September 2023 issue of The American Journal of Managed Care® on the importance of adequate and effective lung cancer risk factor documentation to determine a patient's eligibility for screening.
Listen
Gene Therapy Success in UK Likely Depends on Overcoming Education, Psychological Support Challenges
November 27th 2023Education, psychological support, and implementation guidance are the top unmet needs identified by investigators from the United Kingdom concerning gene therapy use for hemophilia.
Read More
Lawsuits target initiatives aimed at reducing racial disparities; less than 10% of trials for COVID-19 treatments included children in the first 3 years of the pandemic; the World Health Organization requests more information on increased respiratory illnesses in China.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Disease-Modifying Antirheumatic Drugs Linked to Decreased Risk for Autoimmune Thyroid Disease
November 28th 2023A nationwide cohort study linked biologic disease-modifying antirheumatic drugs with decreased risks for the onset of autoimmune thyroid disease in patients with rheumatoid arthritis.
Read More
Insufficient Data, Disparities Plague Lung Cancer Risk Factor Documentation
September 24th 2023On this episode of Managed Care Cast, we speak with the senior author of a study published in the September 2023 issue of The American Journal of Managed Care® on the importance of adequate and effective lung cancer risk factor documentation to determine a patient's eligibility for screening.
Listen
Gene Therapy Success in UK Likely Depends on Overcoming Education, Psychological Support Challenges
November 27th 2023Education, psychological support, and implementation guidance are the top unmet needs identified by investigators from the United Kingdom concerning gene therapy use for hemophilia.
Read More
Lawsuits target initiatives aimed at reducing racial disparities; less than 10% of trials for COVID-19 treatments included children in the first 3 years of the pandemic; the World Health Organization requests more information on increased respiratory illnesses in China.
Read More
2 Clarke Drive
Cranbury, NJ 08512